We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

108 hedge funds and large institutions have $366M invested in Cytokinetics in 2017 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

591% more call options, than puts

Call options by funds: $4.32M | Put options by funds: $626K

75% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 16

21% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 29

13% more capital invested

Capital invested by funds: $323M → $366M (+$42.7M)

7% more funds holding

Funds holding: 101 → 108 (+7)

2.73% more ownership

Funds ownership: 65.48% → 68.21% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
108
Holders Change
+7
Holders Change %
+6.93%
% of All Funds
2.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
28
Increased
35
Reduced
29
Closed
16
Calls
$4.32M
Puts
$626K
Net Calls
+$3.7M
Net Calls Change
+$3.76M

Top Buyers

1
BlackRock
BlackRock
New York
+$35.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.34M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$3.91M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.13M
5
HCMT
Highland Capital Management (Texas)
Texas
+$2.51M

Top Sellers

1
BI
BVF Inc
California
-$6.91M
2
DCM
DAFNA Capital Management
California
-$2.56M
3
WA
Wasatch Advisors
Utah
-$2.09M
4
GC
Globeflex Capital
California
-$1.69M
5
CCMH
Cornerstone Capital Management Holdings
New York
-$1.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$72.7M +$5.34M +456,502 +9%
BI
2
BVF Inc
California
$54.8M -$6.91M -590,855 -12%
BlackRock
3
BlackRock
New York
$39.1M +$35.5M +3,038,630 +93,439%
LPU
4
Lansdowne Partners (UK)
United Kingdom
$29.8M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$25M +$3.13M +267,437 +16%
WA
6
Wasatch Advisors
Utah
$19.2M -$2.09M -178,917 -11%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$17.3M -$544K -46,514 -3%
State Street
8
State Street
Massachusetts
$12M +$405K +34,678 +4%
Citigroup
9
Citigroup
New York
$9.36M -$247K -21,099 -3%
Balyasny Asset Management
10
Balyasny Asset Management
Illinois
$6.52M +$2.13M +181,925 +56%
Millennium Management
11
Millennium Management
New York
$5.2M +$2.26M +192,942 +91%
Northern Trust
12
Northern Trust
Illinois
$4.89M +$66K +5,645 +2%
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$4.3M +$3.91M +334,806 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$3.81M +$137K +11,747 +4%
Morgan Stanley
15
Morgan Stanley
New York
$3.63M +$783K +67,029 +31%
HCMT
16
Highland Capital Management (Texas)
Texas
$2.76M +$2.51M +215,000 New
BIM
17
Bogle Investment Management
Massachusetts
$2.68M +$2.44M +208,781 New
OAM
18
Oxford Asset Management
United Kingdom
$2.49M +$2.27M +193,868 New
Two Sigma Investments
19
Two Sigma Investments
New York
$2.33M +$1.89M +162,094 +839%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$2.15M -$1.01M -86,418 -34%
Russell Investments Group
21
Russell Investments Group
United Kingdom
$2.14M +$1.94M +166,329 New
Charles Schwab
22
Charles Schwab
California
$2.04M +$370K +31,654 +25%
USAA
23
United Services Automobile Association
Texas
$2.02M -$73.3K -6,270 -4%
SFM
24
Sphera Funds Management
Israel
$1.96M +$1.78M +152,200 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$1.92M -$173K -14,834 -9%
1
2 3 4 5

CYTK Hedge Fund Activity: Q1 2017 in Review

108 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q1 2017, worth a combined $366M — up 13% from $323M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new CYTK positions and 16 closed out — a net gain of 12 holders — while 35 added to existing stakes and 29 trimmed.

The largest buyer was BlackRock, adding an estimated $35.5M. The largest seller was BVF Inc, cutting an estimated $6.91M.

  • 108 institutional investors held Cytokinetics (CYTK) as of Q1 2017, up from 101 in Q4 2016.
  • Funds reported $366M of Cytokinetics stock for Q1 2017, up 13% quarter-over-quarter.
  • 28 funds opened new Cytokinetics positions in Q1 2017 and 16 closed out, a net change of +12 holders.
  • The largest Cytokinetics buyer in Q1 2017 was BlackRock, an estimated $35.5M added.
  • The largest Cytokinetics seller in Q1 2017 was BVF Inc, an estimated $6.91M sold.

Based on aggregated 13F filings for Q1 2017.